Company Filing History:
Years Active: 2024
Title: Gaodeng Lian: Innovator in Pharmaceutical Development
Introduction
Gaodeng Lian is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds.
Latest Patents
Lian holds a patent for SHP2 phosphatase inhibitors and methods of making and using the same. This patent is particularly focused on crystalline forms of (R)-1′-(3-(3,4-dihydro-1,5-naphthyridin-1(2H)-yl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-3H-spiro[benzofuran-2,4′-piperidin]-3-amine, its salt, and variants thereof. This invention has the potential to impact therapeutic approaches in various medical conditions.
Career Highlights
Gaodeng Lian is currently associated with Relay Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to innovation and excellence in drug development.
Collaborations
Lian collaborates with esteemed colleagues such as Alexander M. Taylor and André Lescarbeau. These partnerships enhance the research environment and foster the development of groundbreaking solutions in the pharmaceutical industry.
Conclusion
Gaodeng Lian's contributions to pharmaceutical innovation, particularly through his patent on SHP2 phosphatase inhibitors, highlight his role as a key figure in advancing medical science. His ongoing work at Relay Therapeutics, Inc. promises to yield further advancements in the field.